Harbin Jixianglong Biotech Co., Ltd. recalls
2 recalls filed under Harbin Jixianglong Biotech Co., Ltd.. The most recent was published March 11, 2026.
-
Class II · 8 months ago
Harbin Jixianglong Biotech Co., Ltd. Semaglutide recall: CGMP Deviations This recall has been initiated due to failing to complete
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before…
-
Class II · 8 months ago
Harbin Jixianglong Biotech Co., Ltd. Semaglutide recall: CGMP Deviations This recall has been initiated due to failing to complete
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before…
About this page
Harbin Jixianglong Biotech Co., Ltd. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.